...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?

AACR is not going virtual. It is going to be re-scheduled for a later date (not yet announced). Perhaps Zenith will decide to announce the results (at least top-line) prior to the re-scheduled AACR meeting. Or perhaps they will pull out of AACR and disclose the whole enchilada without any embargo restriction. 

https://www.aacr.org/meeting/aacr-annual-meeting-2020/

 

 

 

Share
New Message
Please login to post a reply